Last Updated: July 25, 2026

Patent: 9,120,873

✉ Email this page to a colleague

Summary for Patent: 9,120,873

Title:	Recombinantly produced human factor VIII and IX
Abstract:	A recombinant human factor VIII or IX protein having a human glycosylation pattern but the protein is devoid of N-glycolylneuraminic acid and/or the carbohydrate group Gal.alpha.-3Gal.
Inventor(s):	Sandberg; Helena (Bromma, SE), Stenlund; Peter (Bromma, SE), Schroder; Carola (Neuried, DE), Casademunt; Elisabeth (Munchen, DE), Tiemeyer; Maya (Munchen, DE)
Assignee:	Octapharma AG (Lachen, CH)
Application Number:	12/737,815
Patent Claims:	see list of patent claims

Details for Patent 9,120,873

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Octapharma Pharmazeutika Produktionsges.m.b.h.	NUWIQ	antihemophilic factor (recombinant)	For Injection	125555	September 04, 2015	⤷ Start Trial	2029-08-21
Octapharma Pharmazeutika Produktionsges.m.b.h.	NUWIQ	antihemophilic factor (recombinant)	For Injection	125555	July 07, 2017	⤷ Start Trial	2029-08-21
Octapharma Pharmazeutika Produktionsges.m.b.h.	NUWIQ	antihemophilic factor (recombinant)	For Injection	125555	December 07, 2021	⤷ Start Trial	2029-08-21
Takeda Pharmaceuticals U.s.a., Inc.	VONVENDI	von willebrand factor (recombinant)	For Injection	125577	December 08, 2015	⤷ Start Trial	2029-08-21
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 9,120,873

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
South Africa	201102020	⤷ Start Trial
World Intellectual Property Organization (WIPO)	2010020690	⤷ Start Trial
United States of America	2011262424	⤷ Start Trial
Russian Federation	2011110459	⤷ Start Trial
Mexico	2011001624	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.